
Pharmafocus wants to hear from you!
pharmafile | July 17, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Pharmafocus, biotech, drugs, healthcare, pharma, pharmaceutical
We are always looking for new ways to improve the next issue of Pharmafocus, and now we’re planning a new feature that focuses on you, the reader. Many of you work on the front lines of pharma and life sciences, affected by the issues that we report on every day.
Your insight is invaluable, and we want to hear your experiences and viewpoints on the latest developments and trends as they emerge.
Disagree with the latest drug approval decision? Maybe you, your family, or a patient are affected? Excited about the prospect of a promising set of new research findings? Or even want to discuss a topic as a feature in our regular ‘Opinion’ column? Whether it’s a throwaway observation or extended commentary, we want to hear what you have to say.
Get in touch with us at editorial@pharmafile.com or direct message us on Twitter and share your comments and thoughts – the best could even make it into the upcoming issue.
Related Content

Cellbyte raises $2.75m to fund pharma drug launch platform
Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …

Lilly opens fourth US Gateway Labs site
Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …






